Bonstein Sara's Form 4 filing
INSMED Inc (INSM) · filed Jul 9, 2025
- Accession no.
- 0001604019-25-000003
- Filed
- Jul 9, 2025
- Trade date
- Jul 7, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $5.54M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bonstein SaraCIK 0001604019 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2025 | Common Stock | MOption exerciseAcquired | +6,244 | $19.74 | +$123,256.56 | 100,137 | Direct | |
| Jul 7, 2025 | Common Stock | MOption exerciseAcquired | +4,362 | $24.70 | +$107,741.4 | 104,499 | Direct | |
| Jul 7, 2025 | Common Stock | MOption exerciseAcquired | +23,565 | $26.43 | +$622,822.95 | 128,064 | Direct | |
| Jul 7, 2025 | Common Stock | MOption exerciseAcquired | +13,717 | $26.46 | +$362,951.82 | 141,781 | Direct | |
| Jul 7, 2025 | Common Stock | SSaleDisposed | −35,583 | $95.66F3 | −$3,403,869.78 | 106,198 | Direct | |
| Jul 7, 2025 | Common Stock | SSaleDisposed | −22,181 | $96.19F4 | −$2,133,590.39 | 84,017 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2025 | Common Stock | MOption exerciseDisposed | −6,244 | $0.00 | $0 | 18,880 | Direct | |
| Jul 7, 2025 | Common Stock | MOption exerciseDisposed | −4,362 | $0.00 | $0 | 0 | Direct | |
| Jul 7, 2025 | Common Stock | MOption exerciseDisposed | −23,565 | $0.00 | $0 | 15,710 | Direct | |
| Jul 7, 2025 | Common Stock | MOption exerciseDisposed | −13,717 | $0.00 | $0 | 12,023 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This is the weighted average sales price representing 35,583 shares sold at prices ranging from $95.01 to $96.00 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F4
This is the weighted average sales price representing 22,181 shares sold at prices ranging from $96.01 to $96.95 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.